Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.

Michael Ozga,James S. Blachly,Nicole Grieselhuber,Karilyn Larkin,Alison R. Walker,Bhavana Bhatnagar,Gregory K. Behbehani,Meixiao Long,Tamanna Zohra Haque,Sumithira Vasu,Weiqiang Zhao,Dan Jones,John C. Byrd,Alice S. Mims,Caner Saygin

Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.

2020

Michael Ozga
James S. Blachly
Nicole Grieselhuber
Karilyn Larkin
Alison R. Walker
Bhavana Bhatnagar
Gregory K. Behbehani
Meixiao Long
Tamanna Zohra Haque
Sumithira Vasu
Weiqiang Zhao
Dan Jones
John C. Byrd
Alice S. Mims
Caner Saygin

7515Background: Therapy-related AML (tAML) is a long-term complication of cytotoxic cancer therapy. It is characterized by adverse genetics and inferior survival outcomes when compared to de novo A...

Keywords:

Oncology
Internal medicine
Pathology
Insult
Therapy-Related Acute Myeloid Leukemia
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations